Pharmaceutical company AcelRx Pharmaceuticals announced the appointment of John Saia as general counsel, effective as of April 16.

Saia joins AcelRx from healthcare company McKesson, where he most recently served as corporate secretary and associate general counsel. At McKesson, he served in various roles with increasing responsibilities and leadership, which included leading and supporting nearly 100 acquisitions over this period.

Prior to McKesson, Saia was a senior attorney at DLA Piper, advising clients on capital markets transactions, public reporting, and M&A.  Earlier in his career, Saia was an attorney and special counsel at the U.S. Securities and Exchange Commission.